Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xueming Qian

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society|May 3, 2017
Image Re-Ranking Based on Topic DiversityXueming Qian, Dan Lu, Yaxiong Wang, et al.
IEEE Transactions on Bio-Medical Engineering|November 9, 2023
Forecasting Treatment Outcomes Over Time Using Alternating Deep Sequential ModelsFeng Wu, Guoshuai Zhao, Yuerong Zhou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 7, 2023
[<sup>177</sup>Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft modelsZiqing Zeng, Liqiang Li, Jinping Tao, et al.
Endocrinology|August 24, 2002
Polyethylene glycolated recombinant TNF receptor I improves insulitis and reduces incidence of spontaneous and cyclophosphamide-accelerated diabetes in nonobese diabetic miceJin-Lin Wang, Xueming Qian, Narumol Chinookoswong, et al.
Scientific Reports|March 19, 2022
A contrastive learning approach for ICU false arrhythmia alarm reductionYuerong Zhou, Guoshuai Zhao, Jun Li, et al.
European Journal of Medicinal Chemistry|January 24, 2024
Exploration of radionuclide labeling of a novel scFv-Fc fusion protein targeting CLDN18.2 for tumor diagnosis and treatmentDapeng Li, Lei Ding, Yan Chen, et al.
Scientific Reports|February 17, 2017
A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodiesAnfei Huang, Di Peng, Huanhuan Guo, et al.
Journal of Pharmaceutical Analysis|May 14, 2023
Development of a CLDN18.2-targeting immuno-PET probe for non-invasive imaging in gastrointestinal tumorsYan Chen, Xingguo Hou, Dapeng Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 26, 2023
First-in-human CLDN18.2 functional diagnostic pet imaging of digestive system neoplasms enables whole-body target mapping and lesion detectionShujing Wang, Changsong Qi, Jin Ding, et al.
Cancer Immunology, Immunotherapy : CII|April 28, 2023
Phase I study of MSB2311, a novel pH-dependent anti-PD-L1 monoclonal antibody, treating patients with advanced solid tumors and lymphomaQi Zhang, Jian Zhang, Haijun Zhong, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society|May 3, 2017
Image Re-Ranking Based on Topic DiversityXueming Qian, Dan Lu, Yaxiong Wang, et al.
IEEE Transactions on Bio-Medical Engineering|November 9, 2023
Forecasting Treatment Outcomes Over Time Using Alternating Deep Sequential ModelsFeng Wu, Guoshuai Zhao, Yuerong Zhou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 7, 2023
[<sup>177</sup>Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft modelsZiqing Zeng, Liqiang Li, Jinping Tao, et al.
Endocrinology|August 24, 2002
Polyethylene glycolated recombinant TNF receptor I improves insulitis and reduces incidence of spontaneous and cyclophosphamide-accelerated diabetes in nonobese diabetic miceJin-Lin Wang, Xueming Qian, Narumol Chinookoswong, et al.
Scientific Reports|March 19, 2022
A contrastive learning approach for ICU false arrhythmia alarm reductionYuerong Zhou, Guoshuai Zhao, Jun Li, et al.
European Journal of Medicinal Chemistry|January 24, 2024
Exploration of radionuclide labeling of a novel scFv-Fc fusion protein targeting CLDN18.2 for tumor diagnosis and treatmentDapeng Li, Lei Ding, Yan Chen, et al.
Scientific Reports|February 17, 2017
A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodiesAnfei Huang, Di Peng, Huanhuan Guo, et al.
Journal of Pharmaceutical Analysis|May 14, 2023
Development of a CLDN18.2-targeting immuno-PET probe for non-invasive imaging in gastrointestinal tumorsYan Chen, Xingguo Hou, Dapeng Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 26, 2023
First-in-human CLDN18.2 functional diagnostic pet imaging of digestive system neoplasms enables whole-body target mapping and lesion detectionShujing Wang, Changsong Qi, Jin Ding, et al.
Cancer Immunology, Immunotherapy : CII|April 28, 2023
Phase I study of MSB2311, a novel pH-dependent anti-PD-L1 monoclonal antibody, treating patients with advanced solid tumors and lymphomaQi Zhang, Jian Zhang, Haijun Zhong, et al.
Pageof 4